Normal view

Artificial Wombs: Exploring Ethical Frontiers

2 June 2026 at 21:45

In a groundbreaking development poised to revolutionize neonatal care and reproductive technologies, the emerging field of artificial womb (AW) technology has sparked intense debate among scientists, ethicists, and policymakers. As researchers publish comprehensive scoping reviews that delve into the layered ethical considerations surrounding this cutting-edge technology, it becomes evident that the future of human gestation may soon transcend traditional biological boundaries, raising profound questions about the nature of life, parenthood, and medical intervention.

Artificial wombs, also known as ectogenesis devices, are engineered life-support systems designed to mimic the biological functions of the uterus, allowing premature or otherwise vulnerable fetuses to develop in an artificial environment. Unlike conventional neonatal incubators, artificial wombs aim to recreate the complex physiological conditions that a natural womb provides, including the delivery of oxygen, nutrients, and hormonal signals essential for normal development. This technological innovation holds the potential to dramatically improve survival rates for extremely premature infants, who currently face high risks of mortality and lifelong disability.

Technical strides in AW technology have been propelled by advances in biomaterials, microfluidics, and fetal physiology. Researchers have developed sophisticated bioreactors equipped with synthetic amniotic fluid and artificial placenta interfaces capable of facilitating gas exchange and nutrient delivery while eliminating waste products. These systems simulate the mechanical and chemical environment of the womb, providing a supportive milieu that supports continuous growth and organ maturation. Animal trials have demonstrated promising results, whereby fetal lambs have been maintained inside artificial wombs for several weeks, showing notable development comparable to in utero progression.

Despite these promising advancements, the path to clinical application in humans remains fraught with technical, ethical, and regulatory challenges. One of the critical technical barriers is ensuring the precise control and replication of the uterine environment’s dynamic nature. The uterus is not a static chamber; it orchestrates complex biochemical signaling that influences the fetus’s epigenetic programming, immune system development, and neurocognitive growth. Achieving such a level of biomimicry requires integrating real-time monitoring technologies with adaptive feedback mechanisms, demanding unprecedented interdisciplinary collaboration.

The ethical dimensions introduced by artificial womb technology extend far beyond the scope of conventional neonatal care protocols. Principally, AW technology disrupts conventional understandings of gestation’s biological and social parameters. By decoupling gestation from the maternal body, it challenges the traditional gestational kinship and raises questions about the legal and moral status of the fetus under artificial care. This separation provokes debates over parental rights, responsibilities, and the potential redefinition of motherhood. Furthermore, the prospect of ectogenesis stirs societal concerns regarding reproductive autonomy, inequality, and the commodification of fetal development.

A particularly contentious aspect of artificial womb deployment pertains to the concept of viability—the gestational age at which a fetus can survive ex utero, a legal and medical benchmark for debates on abortion rights and neonatal care decisions. With AW technology potentially lowering the threshold of viability to much earlier gestational stages, this criterion could face unprecedented challenges. Ethical frameworks would need to adapt to the expanded range of survivable gestational ages, potentially reshaping public health policies and reproductive laws worldwide.

Moreover, the ramifications for fetuses with congenital abnormalities or those requiring intensive medical interventions raise critical ethical considerations. Artificial wombs could theoretically preserve and nurture fetuses previously deemed nonviable, complicating decisions about the extent of medical care and quality of life assessments. This possibility calls for robust ethical guidelines balancing the benefits of survival with respect for individual dignity and long-term outcomes.

Privacy and consent issues also loom large in this emerging field. The intimate nature of gestation, traditionally confined within the maternal body, would be externalized and subject to clinical control and technological mediation. This transition demands rigorous protocols to ensure informed consent, data privacy, and the protection of vulnerable subjects in artificial gestation settings. The question arises whether future parents or guardians can fully comprehend the implications of entrusting fetal development to machines, necessitating enhanced counseling and oversight frameworks.

Furthermore, artificial womb technology raises significant social justice concerns. Access to such advanced reproductive technologies may be limited by socioeconomic status, healthcare infrastructure, and geographic location, potentially exacerbating existing disparities in neonatal outcomes. Policymakers must therefore anticipate and address inequities in availability to prevent the widening of healthcare gaps, ensuring that AW benefits are equitably distributed.

From a psychological perspective, the impact on parent-child bonding when gestation occurs outside the maternal womb remains largely unexplored. The intimate physical and hormonal interactions during pregnancy play a pivotal role in maternal-fetal attachment and subsequent family dynamics. The absence of direct gestational involvement may influence parental bonding, emotional well-being, and child development, indicating the need for comprehensive psychological support and long-term studies.

On the regulatory front, global frameworks governing artificial womb technology are nascent and heterogeneous. Establishing consistent guidelines to oversee research, clinical trials, and eventual clinical use will require international cooperation among scientific bodies, bioethicists, and governmental agencies. Regulatory oversight must balance the encouragement of innovation with safeguarding against premature or unethical applications.

Importantly, public perception and societal acceptance will significantly influence the trajectory of artificial womb technology. Public engagement initiatives, transparency in research practices, and inclusive dialogues are essential to fostering trust and understanding. Addressing fears of “unnatural” reproduction and debunking misconceptions will be critical to integrating AW technology into mainstream medical practice sensitively.

As AW research progresses toward clinical reality, multidisciplinary collaboration will be imperative. Biomedical engineers, neonatologists, ethicists, sociologists, and lawmakers must converge to navigate the complex scientific and moral landscape. The responsible development of artificial womb technology entails anticipatory governance that proactively identifies and mitigates risks while amplifying potential benefits.

In conclusion, artificial womb technology represents a paradigm shift with monumental implications for medicine, ethics, and society. While offering hope to improve neonatal survival and reimagine reproductive possibilities, it simultaneously demands careful scrutiny of the profound ethical questions it raises. The journey from experimental prototypes to clinical tools will require deliberate, informed deliberation, ensuring that this revolutionary technology serves humanity’s best interests without compromising foundational values.

As ongoing research continues to unravel the intricacies of artificial gestation, the global community stands at a crossroads. The choices made today will sculpt the future of human reproduction and neonatal care, exemplifying the delicate interplay between scientific innovation and ethical responsibility. The promise of artificial wombs invites us to reconsider not only how life begins but also the societal frameworks that sustain it in an ever-evolving biomedical era.


Subject of Research:
Ethical considerations surrounding artificial womb technology and its implications for neonatal care and reproductive medicine.

Article Title:
Correction: Artificial womb technology; a scoping review of ethical considerations.

Article References:
De Bie, F.R., Paul, J., Malek, J. et al. Correction: Artificial womb technology; a scoping review of ethical considerations. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02746-2

Image Credits:
AI Generated

This Neuralink Patient is Transforming Thoughts Into Art in a New Brain-Computer Interface Breakthrough

20 May 2026 at 17:56


Neuralink’s first female PRIME trial participant, Audrey Crews, is now creating abstract art using the company’s brain-computer interface.

Crews, who was paralyzed from the neck down at age 16, has been creating memorable abstract art with her mind using an innovative brain-computer interface (BCI) technology.

Crews is the 9th Neuralink participant and the first woman to receive the implantable device in the PRIME clinical trials.  

After a car accident left her paralyzed from the neck down, Audrey didn’t think she would be able to draw or paint again.

20 years later, she became the first female participant in our clinical trials. Now, she uses her brain-computer interface to create art with her mind. pic.twitter.com/mRkJMDpgrM

— Neuralink (@neuralink) May 15, 2026

With fewer than 100 people worldwide with BCIs, Crews has found herself at the intersection of art and the future of bneuroscience. By using only the power of thought, Crews has created vibrant abstract art with rich color and shapes.

On her website, she explains why creating this art is important to her: “My mission is to expand the boundaries of human expression and share the u

nseen landscapes of the mind,” Crews says. 

Her artwork has evolved stylistically since her first showcase on X in 2025, at which time she was learning to draw her name.

“I tried writing my name for the first time in 20 years. Im working on it,” Crews said in a post on X

“I’ll never forget the moment I used my thoughts to write my name, ‘Audrey,’ on a laptop screen for the first time in two decades. I even drew hearts and a slice of pizza, which felt like a small miracle! I shared that moment on X, laughing about my progress,” Crews said on her website.

“It’s humbling to know my journey is helping Neuralink refine this technology, which could one day let millions control devices with their minds,” she added.  

Since then, Crews’ art has evolved, and she has also launched her online NeuraArt Studio, where fans can purchase limited-edition prints of her artwork.

Amid the BCI company’s efforts, Neuralink states that its devices are still “investigational and not FDA approved.” 

However, in January of this year, the company said in a statement that a “primary ‌aim of our expanding clinical trials is to better understand these variations and improve both our hardware and the overall procedure for every participant.”

Neuralink began human trials of its brain implant in 2024 after resolving safety concerns raised by the U.S. Food and Drug Administration, which had previously declined to approve its initial application in 2022.

For Crews, what she has achieved lies at the intersection of current implantable BCI technology and fine abstract art, signaling a fundamental reframing of what it means to create, perceive, and even experience such creative products—a shift from something merely observed to something partially constructed by BCI users through thought.

“This breakthrough didn’t just restore my ability to create—it ignited a passion for art that had been dormant for too long,” she says. Crews’ art can be viewed, and prints are available for purchase, on her NeuraArt Studio website.

Chrissy Newton is a PR professional and the founder of VOCAB Communications. She currently appears on The Discovery Channel and Max and hosts the Rebelliously Curious podcast, which can be found on YouTube and on all audio podcast streaming platforms. Follow her on X: @ChrissyNewton, Instagram: @BeingChrissyNewton, and chrissynewton.com. To contact Chrissy with a story, please email chrissy @ thedebrief.org.

Convicted Harvard Scientist Rebuilds Career in China Through Controversial Brain-Computer Interface Lab

19 May 2026 at 13:47


A former Harvard chemistry professor convicted in the United States for concealing ties to a Chinese talent program is now leading a state-backed brain-computer interface laboratory in Shenzhen, raising fresh concerns about the geopolitical race for emerging technologies.

Former Harvard scientist Charles Lieber, 67, has rebuilt his research career in China, where he currently directs the Institute for Brain Research, Advanced Interfaces and Neurotechnologies (i-BRAIN). In 2021, he was convicted in the United States for lying to federal investigators about his financial ties to a Chinese talent recruitment program, as well as for tax-related offenses. He was sentenced to prison and later placed under home confinement before relocating to Shenzhen in 2025.

Considered a leading authority in BCI research and development, Lieber now serves as director of i-BRAIN, a laboratory operating under the Shenzhen Medical Academy of Research and Translation (SMART), a government-backed institution. The laboratory’s primary focus includes primate research and BCI chip development.

Lieber said during a Shenzhen government news conference in December, “I arrived on April 28, 2025, with a dream and not much more, maybe a couple bags of clothes.” He added, “Personally, my own goals are to make Shenzhen a world leader.”

According to Reuters, the lab provides Lieber with resources beyond what he had access to in the United States, including dedicated nanofabrication equipment and extensive primate research facilities.

Experts have previously warned U.S. officials and Congress about the privacy implications of BCI technologies, as well as potential military applications that enhance cognitive performance on and off the battlefield. Lieber’s return to cutting-edge research has renewed debate in the United States over technology security and scientific cooperation with China.

“China has weaponized against us our own openness and our own efforts for innovation,” Glenn Gerstell, an advisor at the Center for Strategic and International Studies and former general counsel for the U.S. National Security Agency (NSA), told Reuters on  May 1. “They’ve flipped that and turned it around against us, and they’re ​taking advantage of it.”

China’s policy of “military-civil fusion,” which encourages collaboration between civilian research institutions and the military, has increased those concerns in the United States. In July 2025, the Chinese government announced its goal of becoming the “gold standard” for BCI competitors worldwide. 

At i-BRAIN, Lieber’s team is reportedly currently hiring international researchers to conduct experiments involving rhesus monkeys, which have been used for BCI testing at many other companies, such as Elon Musk’s Neuralink.

In recent years, Neuralink employees have reported ongoing mistreatment and deaths of rhesus monkeys, where death certificates are openly available to see. But Musk took to the popular social media outlet X, stating that “No monkey has died as a result of a Neuralink implant. First, our early implants, to minimize risk to healthy monkeys, we chose terminal monkeys (close to death already).”

The i-BRAIN lab also offers chip-manufacturing tools, including ultraviolet lithography systems used to create tiny electronic circuits. 

Washington and Wall Street Brace for the BCI Era

In October of last year, Morgan Stanley released a private report titled, “Neuralink: AI in your brAIn” addressing that Elon Musk and Neuralink are at the forefront of a larger technological shift that society may not be ready for: one with staggering implications that could ultimately impact everything from healthcare to gaming, defense, investing, and society at large. The report also addressed the challenges of a potential “neuro-elite” evolving over time. 

“As AI moves into the physical world through expressions ranging from robotaxis to humanoids and autonomous weapons systems, we recommend paying closer attention to developments in brain-computer interface,” a portion of the paper states, under a section titled “Prometheus Shrugged.”

A month before this report was released, on September 24, Senate Majority Leader Chuck Schumer, along with Senators John Cornyn and Ron Wyden, proposed legislation to regulate BCIs, requesting that the FTC review the policy for long-term use.

Named the MIND Act, guidelines should be created alongside a framework to address ethical concerns and safeguard American interests.

Altogether, as the race to merge minds and machines intensifies, the broader consequences of who controls these technologies—and how they are used—remain in question.

Chrissy Newton is a PR professional and the founder of VOCAB Communications. She currently appears on The Discovery Channel and Max and hosts the Rebelliously Curious podcast, which can be found on YouTube and on all audio podcast streaming platforms. Follow her on X: @ChrissyNewton, Instagram: @BeingChrissyNewton, and chrissynewton.com. To contact Chrissy with a story, please email chrissy @ thedebrief.org.

Rethinking Consciousness: Could Everything From Animals to AI Be Aware?

18 May 2026 at 13:38


Traditionally, consciousness has been treated as an exclusive club. Humans are unquestionably members. Most animals are often assumed to be on the outside. Plants, fungi, bacteria, and machines are typically regarded as little more than biological or mechanical systems lacking any real awareness.

However, a recent review published in Frontiers in Psychology argues that science could be asking the wrong questions and making incorrect assumptions about consciousness.

Dr. Jeff Sebo, a philosopher and professor of environmental studies and bioethics at New York University, explores an intriguing issue in modern science and philosophy: what kinds of beings should we assume are conscious before definitive proof exists.

Rather than focusing only on humans or familiar animals, Dr. Sebo’s analysis examines whether plants, fungi, bacteria, AI systems, robots, and perhaps even all matter itself could possess some form of subjective experience.

While it may sound like a mere philosophical debate, perceptions of what qualifies as consciousness influence a wide range of fields, from biomedical research to the ethical principles guiding humanity’s relationship with nature and emerging technologies.

“Questions about the distribution of consciousness in the world arise constantly in both science and ethics,” Dr. Sebo writes. “These assumptions shape everything from research design and laboratory protocols to farming practices and wildlife management policies.”

Historically, science has often assumed that nonhuman beings lack consciousness. Over the past few decades, however, a growing body of research has increasingly challenged that view, with studies suggesting that many animals—including chimpanzees, dolphins, octopuses, and even insects—possess surprisingly sophisticated cognitive abilities and can exhibit signs of self-awareness, emotion, planning, and tool use.

In 2024, forty scientists and philosophers, including Dr. Sebo, signed the New York Declaration on Animal Consciousness. The decree states that, based on the mounting empirical evidence, there is a “realistic possibility of conscious experience” in many animals. Support for the declaration has expanded dramatically, with the number of signatories growing to nearly 600 scientists and philosophers as of May 2026.

In his recent paper, Dr. Sebo takes the consciousness debate further by challenging the long-standing assumption that nonhuman beings lack consciousness unless overwhelming evidence proves otherwise. He argues that this default skepticism may actually be holding science back.

“The traditional skeptical assumption about nonhuman consciousness may be too restrictive given the current state of evidence and theory,” Dr. Sebo writes. “When we search for evidence with an open mind and non-anthropocentric methods, we tend to find at least some indicators of subjective awareness across a wide range of biological and artificial systems.”  

Instead of treating consciousness as a simple yes-or-no question, Dr. Sebo analyzes several possibilities for how consciousness may be distributed across the natural and artificial world, and examines the default assumptions scientists use when evidence remains uncertain.

One possibility is that all animals are conscious. Similarly, the concept holds that all living beings are conscious, including plants and fungi. A third prospect is the idea that any organism capable of processing sensory information may possess awareness. Another approach centers on complex cognition, potentially extending consciousness to future AI systems.

The most radical possibility is panpsychism, the philosophical idea that consciousness is a fundamental property of matter itself. However, Dr. Sebo cautions that even if simple forms of consciousness existed at the level of matter, further theory would be needed to explain how, or whether, complex conscious experience emerges in larger systems.

Dr. Sebo does not argue that a single default assumption about consciousness is always best. Instead, he argues that scientists and ethicists may need different assumptions for different purposes, depending on the evidence, the research question, and the ethical risks involved.

“We should select different default assumptions about the distribution of consciousness for different purposes and in different contexts, both within and beyond the animal kingdom,” Dr. Sebo writes. “Overall, the aim is to balance theoretical rigor with practical progress, recognizing that assumptions work differently when taken as truth claims and when taken as mere tools.”

One of the central challenges to understanding consciousness is that it remains notoriously difficult to study.

Scientists can observe behavior, brain activity, and information processing, but subjective experience itself cannot be directly accessed from the outside. In philosophy, this is known as the “problem of other minds.” Humans cannot directly verify another being’s inner experience in the same way they can access their own.

“We can directly observe behaviors and anatomies, but not thoughts and feelings,” Dr. Sebo writes. “These epistemic barriers limit our ability to draw firm conclusions about which beings are conscious.”

The inherent inability to observe subjective awareness has led researchers to develop new approaches, including the search for so-called “markers” of consciousness in animals and even in AI systems. By comparing humans and nonhumans, scientists hope to identify similarities that indicate the presence of subjective experiences in animals and in technology.

However, these techniques may have significant limitations because they rely heavily on identifying markers that resemble human consciousness. If consciousness exists in many forms, some animals and potentially future AI systems could exhibit signs of awareness fundamentally alien to human experience, making them much harder for researchers to recognize.

The paper also revisits the so-called “hard problem of consciousness,” the enduring mystery of how physical systems like brains produce subjective experience at all. Even if neuroscience eventually explains how the brain processes information, researchers will still struggle to explain why those processes feel like something from the inside.

Because of the profound uncertainties surrounding consciousness, Dr. Sebo argues that rigid skepticism toward nonhuman awareness may no longer be scientifically justified. Instead, he suggests researchers may benefit from a more flexible, probabilistic approach. Rather than treating entities as either conscious or mindless, scientists could assign varying probabilities of consciousness based on the available evidence.

Adopting this more holistic approach to consciousness could have profound ethical implications, as it would force people to rethink their attitudes towards animals, plants, and artificial intelligence.

If a creature or machine has even a modest chance of experiencing suffering, Dr. Sebo argues society may need to consider the moral risks of ignoring that possibility. Mistakenly treating a conscious being as a mere object could allow enormous harm.

The analysis compares the dangers of false positives and false negatives. Mistakenly treating a nonconscious object as conscious could waste resources or encourage unnecessary emotional attachment. But mistakenly treating a conscious being as though it lacks feelings or awareness could allow suffering on a massive scale.

“At the theoretical level, our defaults should ideally balance the risk of false positives and the risk of false negatives,” Dr. Sebo writes. “At the practical level, our defaults should also reflect what particular agents are able to achieve and sustain at present and what will build momentum toward a better calibrated moral circle in the future.”

The argument becomes especially complicated in the context of artificial intelligence. As Dr. Sebo notes, advanced AI systems could eventually force society into deeply difficult ethical territory.

On the one hand, if future AI systems become capable of mimicking human behavior convincingly enough to persuade society they are conscious, people may eventually face pressure to grant them rights or legal protections.

On the other hand, the paper argues that granting rights or political standing to machines that are not actually conscious could create serious societal dangers. Beyond deepening humanity’s dependence on advanced technologies, Dr. Sebo notes that some experts warn such decisions could even introduce existential risks if increasingly powerful AI systems were treated as entities with genuine moral or political standing.

“The result could be human disempowerment, perhaps even extinction—all for the sake of entities with no inner mental life,” Dr. Sebo writes.

At the same time, Dr. Sebo cautions against dismissing AI consciousness outright under a default stance of skepticism. He notes science’s long history of underestimating animal consciousness serves as a warning about the risks of assuming unfamiliar minds are impossible.

Rather than arguing for a single universal standard, Dr. Sebo emphasizes that different situations may require different assumptions about consciousness. Scientific theory, practical research, ethical theory, and real-world policymaking all involve different risks and goals, meaning each may require its own approach.

For example, scientists trying to open new lines of research may benefit from broader assumptions about consciousness, while policymakers designing regulations may need more cautious, incremental standards.

One of the paper’s most striking themes is that consciousness may not be a rare phenomenon restricted to humans and a handful of advanced animals. Instead, the universe may contain a far wider spectrum of minds than humanity can currently imagine.

That possibility carries profound implications for fields ranging from neuroscience and philosophy to agriculture, environmental policy, robotics, AI development, and even the search for extraterrestrial life.

Ultimately, the idea also raises deeply unsettling questions about humanity’s relationship with the rest of existence—and whether people may have vastly underestimated the presence of conscious experience in the world around them.

“The stakes of our default assumptions about the distribution of consciousness are high,” Dr. Sebo concludes. “As progress continues, our default assumptions about the distribution of consciousness could shape our decisions in a range of contexts, determining the trajectory of consciousness science and the fates of countless entities.”

Tim McMillan is a retired law enforcement executive, investigative reporter and co-founder of The Debrief. His writing typically focuses on defense, national security, the Intelligence Community and topics related to psychology. You can follow Tim on Twitter: @LtTimMcMillan.  Tim can be reached by email: tim@thedebrief.org or through encrypted email: LtTimMcMillan@protonmail.com 

Neighbors Horrified by Data Center Twice the Size of Manhattan

1 June 2026 at 15:49

TV personality and businessman Kevin O’Leary is looking to construct a mammoth data center facility more than twice the size of Manhattan in Utah’s broader Salt Lake City region.

As Slate reports, the megalomaniac plans for the “Stratos Hyperscale Data Center” would see dozens of data center buildings, research facilities, and even worker housing be constructed across 40,000 acres of unincorporated land in Box Elder County, which is home to over 60,000 residents.

Given the widespread backlash to data centers across the entire country, it shouldn’t come as a surprise that many of these residents are now rushing to council meetings to forcefully refute the plans. After all, they’ve watched as other areas that welcome the facilities struggle with rising electricity prices, stressed water systems, and noise pollution.

Worse yet, the Great Salt Lake is already in crisis: it’s rapidly disappearing amid devastating droughts across the state. An extremely resource-intensive data center could place a massive new strain on it, regardless of the many reassurances from developers.

Despite initially setting aside a vote on the Stratos construction project, county commissioners eventually pushed forward, arguing that they had the “obligation” to start building, as Slate reports.

The debate drew thousands of negative comments, with hundreds of angry residents piling into a May 4 commission meeting, an all-too-familiar sight as countless Americans are desperately trying to publicly denounce plans for similar data centers in their counties.

Behind closed doors, Box Elder County commissioners eventually approved the data center, triggering an even louder outcry. Meanwhile, county attorneys argue that voters don’t have a legal say in the matter, rejecting a push for a referendum. As the Salt Lake Tribune reported last week, opponents said they were looking to take legal action after being shut out of the approval process.

“To me, and to other people I’ve talked to, it felt like it was done in the dark: backroom deals and assurances made with no transparency or government accountability,” Salt Lake City resident Larry Curtis told Slate.

Stratos remains adamant that the data center will be a boon for the region, creating 2,000 permanent jobs. Critics, though, say that figure is far too small for the sheer scale of the operation.

It’d be a fraught debate anywhere, but the backdrop here is grim: residents have been watching as the Great Salt Lake continues to shrink, with snow and rain becoming extremely sparse.

“In the past, one thing I could’ve agreed with [Utah governor Spencer Cox] on was that we need to save the lake,” resident Stephen Otterstrom told Slate. “Now this puts into question whether there is any sincerity in that.”

Yet the tides could soon start to change as the public blowback grows. The outcry has been loud enough for local politicians to backpedal after initially supporting the data center, as they realize it’s a major liability that could endanger their chances of being reelected.

More on data centers: You’ll Never Guess Trade Unions’ Position on AI Data Centers

The post Neighbors Horrified by Data Center Twice the Size of Manhattan appeared first on Futurism.

❌